United Kingdom· GB-APID-40861711000001103
Kimmtrak 100micrograms/0.5ml concentrate for solution for infusion vials
A tebentafusp product containing tebentafusp, registered in United Kingdom by Immunocore Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Tebentafusp is registered in 11 of 19 countries.
Countries holding a registration under ATC L01XX75 (tebentafusp), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Tebentafusp · ATC L01XX75
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tebentafusp costs, country by country.
Normalised to the WHO defined daily dose (9.7 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tebentafusp · price per daily dose (9.7 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$1341.35
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tebentafusp
- Manufacturer
- Immunocore Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XX75
- ATC class
- Tebentafusp
- Defined daily dose
- 9.7 mcg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5056416800029
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tebentafusp in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKIMMTRAKImmunocore Commercial LLC
- CanadaKIMMTRAKIMMUNOCORE IRELAND LIMITED
- SwitzerlandKimmtrak
- CzechiaKIMMTRAKImmunocore Ireland Limited, Dublin
- SpainKIMMTRAK 100 MICROGRAMOS/0,5 ML CONCENTRADO PARA SOLUCION PARA PERFUSIONImmunocore Ireland Limited
- FinlandKIMMTRAKImmunocore Ireland Limited
- FranceKIMMTRAK 100 microgrammes/0,5 mL, solution à diluer pour perfusionIMMUNOCORE IRELAND (IRLANDE)
- BelgiumKimmtrak 100 µg/0.5 mlImmunocore Ireland
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kimmtrak
- Liechtenstein · Kimmtrak
- Norway · Kimmtrak
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a3c144af-00a3-4aab-9ded-d2a0330837c8 GET /v1/drugs/a3c144af-00a3-4aab-9ded-d2a0330837c8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40861711000001103",
"desc": "Kimmtrak 100micrograms/0.5ml concentrate for solution for infusion vials (Immunocore Ltd)",
"form": "Solution for infusion",
"vpid": "40874711000001107",
"source": "dmd",
"vtm_id": "40865911000001104",
"strength": "200 microgram",
"substance": "Tebentafusp",
"ingredient": "Tebentafusp",
"supplier_code": "40861011000001100"
}See everything about tebentafusp.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.